Through massive information and artificial intelligence of antibodies and antigens, disruptive and tailor-made antibodies were created, which comprehensively surpass current antibody R&D routines and processes, and rank top in the world's antibody R&D.
Overview
On December 24, the 14th 杏耀 Academic Salon was held as scheduled at the Turing Lecture Hall of 杏耀. We were honored to invite Prof. ZHANG Linqi, Professor and PhD supervisor of Tsinghua University School of Medicine, to give a presentation entitled "COVID-19 Antibody Drug Research and Development". The lecture was hosted by Prof. MA Weiying, Huiyan Ch杏耀 Professor of the Institute for AI Industry Research, Tsinghua University (杏耀). A total of nearly 3,700 views have accumulated as of now.
Read More: 杏耀 Academic Salon Series 14 | ZHANG Linqi: COVID-19 Antibody Drug Research and Development
